PMDA — authorised 23 July 2010
- Marketing authorisation holder: Bayer Yakuhin, Ltd.
- Status: approved
PMDA authorised Slynd on 23 July 2010
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 July 2010.
Bayer Yakuhin, Ltd. holds the Japanese marketing authorisation.